Essity Ab Class A · OMXSTO:ESSITY_A
Essity Ab Class A — Q2 2025 Earnings Presentation
19 slides from Essity Ab Class A's earnings presentation, Jul 17, 2025
Slide 1: Interim Report Quarter 2, 2025
Interim Report Quarter 2, 2025 July 17, 2025
Slide 2: Ulrika Kolsrud, President and CEO
Ulrika Kolsrud President and CEO
Slide 3: Highlights Q2 2025
Highlights Q2 2025 Stability in a challenging world Organic Sales Growth EBITA excl IAC • Positive organic sales growth • Strong growth in strategic segments +4.6% SEK +1.9% Organic: 4,693m • Weak economy and uncertain environment lead to +3.8% limited volume growth • High pace of product launches E
Slide 4: Health & Medical
Health & Medical Business highlights • Growing Medical Solutions for 17 consecutive quarters • Weaker conditions in specific markets impacted Incontinence Care Health care • Continued underlying strong demand for solutions addressing chronic conditions • Launch of TENA Bariatric Range, 3XL-4XL
Slide 5: Consumer Goods
Consumer Goods Business highlights • Strong growth in Incontinence Care Retail and Feminine Care • Baby Care challenged by competitive pressure – targeted activities to come back to growth • Consumer Tissue growth in low/mid tier segments • Strong launches along good-better-best spectrum 5
Slide 6: Never just a period
eA. Never just a period
Slide 7: Professional Hygiene
Professional Hygiene Business highlights • Good growth in strategic products • Challenging market conditions both in North America and Europe, especially in HoReCa • Selective price management • Launch of Tork Matic® Sensor Dispenser with 6 years battery time
Slide 8: Tork OptiServe - Coreless Toilet Paper System
Tork OptiServe - Coreless Toilet Paper System launched end of 2024 with successful market reception and prestigious wins e.g. Yankee stadium
Slide 9: Essity awarded
Essity awarded supplier engagement leader by CDP and confirmed constituent of the FTSE4Good Index Series
Slide 10: Fredrik Rystedt, Executive Vice President and CFO
Fredrik Rystedt Executive Vice President and CFO
Slide 11: Stable volumes and higher sales prices
Stable volumes and higher sales prices 36.6 +0.2% +1.7% -8.5% Organic 34.2 Sales Growth + Consumer Goods + Consumer Goods Health & Medical +0.1% +/- Health & Medical +/- Health & Medical - Professional Hygiene + Professional Hygiene • Incontinence Health Care -1.4% • Medical Solutions +2.0% Consumer
Slide 12: EBITA margin excl. IAC
EBITA margin excl. IAC 14.7% +20bps +20bps -120bps -20bps 13.7% + Higher sales prices + Higher volumes - Higher COGS EBITA margin excl. IAC Health & Medical 17.2% Consumer Goods 12.8% Professional Hygiene 16.9% Q2 2024 Impact Gross A&P SG&A Other Q2 2025 Profit Margin (excl. A&P) Interim Report, Qua
Slide 13: Cash flow generation
Cash flow generation Operating Cash flow SEKbn 6.5 6.1 5.9 4.3 3.8 3.2 3.3 2.8 1.5 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Interim Report, Quarter 2, 2025 13
Slide 14: Strong balance sheet
Strong balance sheet SEKbn 70 5 62.9 4,5 60 53.7 4 50 3,5 3 40 3.1 34.2 30.8 2,5 30 2 20 2.0 1,5 1 10 1.2 1.3 0,5 0 0 2022 2023 2024 6M 2025 Net Debt, SEKbn Net Debt / EBITDA excl. IAC Interim Report, Quarter 2, 2025 14
Slide 15: Ulrika Kolsrud, President and CEO
Ulrika Kolsrud President and CEO
Slide 16: Summary
Summary • Q2 - Organic growth and stable profit in a weak economy – Lower volume growth than expected – Strong growth in strategic segments – High pace of product launches – Stable profitability although impacted by low volume growth and higher costs • Priorities 2025 – Continue to execute on our st
Slide 17: Every day our brands care for the hygiene and health of a billion people
This presentation may contain forward-looking statements. Such statements are based on our current expectations and are subject to certain risks and uncertainties that could negatively affect our business. Please read our most recent annual report for a better understanding of these risks and uncert
Slide 18: Q&A
Q&A 18
Slide 19: Essity
ée> essity TORK coe €Ccutimed’ Livero Wy Sy WY eS eo